Article
A novel DRD2 single-nucleotide polymorphism associated with schizophrenia predicts age of onset: HapMap tag-single-nucleotide polymorphism analysis.
Genetic testing and molecular biomarkers - 1 Feb 2012
Voisey Joanne, Swagell Christopher D, Hughes Ian P, Lawford Bruce R, Young Ross McD, Morris Charles Phillip
Abstract excerpt
BACKGROUND: Dopamine D2 receptor (DRD2) is thought to be critical in regulating the dopaminergic pathway in the brain, which is known to be important in the etiology of schizophrenia. It is, therefore, not surprising that most antipsychotic medication acts on DRD2. DRD2 is widely expressed in the brain; levels are reduced in the brains of patients with schizophrenia, and DRD2 polymorphisms have been associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
